Plaatm1(NCOM)Cmhd
Targeted Allele Detail
|
Symbol: |
Plaatm1(NCOM)Cmhd |
Name: |
phospholipase A2, activating protein; targeted mutation 1, Centre for Modeling Human Disease |
MGI ID: |
MGI:4880046 |
Gene: |
Plaa Location: Chr4:94455751-94491481 bp, - strand Genetic Position: Chr4, 43.34 cM
|
Alliance: |
Plaatm1(NCOM)Cmhd page
|
IMPC: |
Plaa gene page |
|
Mutant Cell Lines: |
N00108P0_C_26T_A1, N00108P0_C_26T_A2, N00108P0_C_26T_B1, N00108P0_C_26T_B2, N00108P0_C_26T_D1, N00108P0_C_26T_D2, N00108P0_C_26T_E1, N00108P0_C_26T_E2, N00108P0_C_26T_F1, N00108P0_C_26T_G1 |
Germline Transmission: |
Earliest citation of germline transmission:
J:240526
|
Parent Cell Line: |
C2 (Tcp) (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
NorCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_NTARU-2
|
|
|
Mutation details: The insertion of NorCOMM cassette pNTARU created a deletion of size 918bp between positions 94477861-94478779 of Chromosome 4 (Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an F3 site followed by a universal inverse PCR primer site and a splice acceptor lacZ-neomycin phosphotransferase fusion (beta-geo) sequence. This is followed by a PhiC31 attP site and a puromycin sequence that is not active unless a promoter is inserted by PhiC31 at the attP site. The cassette is finished with an FRT site. Variations of this allele can be made using PhiC31 docking and subsequent cloning (Nagy et al., 2009. Methods Mol. Biol. 530:365-78).
(J:165963)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Plaa Mutation: |
47 strains or lines available
|
|
Original: |
J:165963 Centre for Modeling Human Disease, Alleles produced for the NorCOMM project by the Centre for Modeling Human Disease (Cmhd), Institute of Biomaterials & Biomedical Engineering, University of Toronto. MGI Direct Data Submission. 2010; |
All: |
2 reference(s) |
|